ISB News

ISB Innovations: Ultrasound-Based Tumor Biopsies

John Chevillet is a postdoc in the Hood Lab at Institute for Systems Biology in Seattle.
Name:

John Chevillet, PhD

Lab:

Hood

Research:

I am trying to develop an ultrasound-based method to take a sample from a tumor, thus replacing needle biopsies. An ultrasound-based method would minimize complications, better diagnose cancers, and direct the use of targeted therapies for personalized medicine.

Wish List:

If I had $10,000, I could analyze the blood specimens we currently have for cancer dna to demonstrate what this method can tell us about the mutations driving a tumor. If I had $100,000, I could analyze a wide spectrum of molecules (DNA, RNA and protein) and start to define a biomarker signature panel that could be used as a foundation for a test more accurate than what we have now. If I had $1 million, I could partner with physicians and patients to test this method.

How you can help:

Watch this short video and click the button at the end of the video. Or donate now.

If you have questions about this project or would like to speak directly with our researchers, contact us.

 

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.